Simplex Trading
ONCT

Simplex Trading’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

Simplex Trading’s Portfolio ONCT Stock Details ONCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-356
Closed -$5K – 10269
2023
Q1 		$5K Sell
356
-24
-6% -$472 ﹤0.01% 8111
2022
Q4 		$7K Buy
380
+114
+43% +$2.27K ﹤0.01% 7886
2022
Q3 		$4K Sell
266
-2,808
-91% -$60.2K ﹤0.01% 9004
2022
Q2 		$68K Buy
3,074
+1,272
+71% +$28.4K ﹤0.01% 6084
2022
Q1 		$50K Buy
1,802
+1,307
+264% +$47.6K ﹤0.01% 7144
2021
Q4 		$22K Sell
495
-1,889
-79% -$127K ﹤0.01% 8280
2021
Q3 		$226K Hold
2,384
– – ﹤0.01% 5407
2021
Q2 		$226K Buy
2,384
+466
+24% +$55.3K ﹤0.01% 5496
2021
Q1 		$319K Buy
1,918
+1,751
+1,049% +$232K ﹤0.01% 4075
2020
Q4 		$16K Buy
+167
New +$10.6K ﹤0.01% 7137
2018
Q3 		– Sell
-2
Closed -$4.8K – 8248
2018
Q2 		$3K Buy
+2
New +$5.07K ﹤0.01% 6967
2017
Q3 		– Sell
-18
Closed -$13K – 6841
2017
Q2 		$13K Buy
+18
New +$11K ﹤0.01% 3759
2017
Q1 		– Hold
0
– – – 6944
2016
Q4 		– Hold
0
– – – 6719
2016
Q1 		– Sell
-2
Closed -$2K – 6424
2015
Q4 		$2K Hold
2
– – ﹤0.01% 4640
2015
Q3 		$2K Sell
2
-3
-60% -$4.38K ﹤0.01% 4773
2015
Q2 		$10K Buy
5
+3
+150% +$4.26K ﹤0.01% 3084
2015
Q1 		$2K Hold
2
– – ﹤0.01% 4234
2014
Q4 		$2K Buy
+2
New +$1.78K ﹤0.01% 3853

Other funds holding ONCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
QPW
Quantum Private Wealth Tampa, Florida $390M AUM 58.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Simplex Trading's ONCT Position: Q2 2023 in Review

Simplex Trading sold out of Oncternal Therapeutics, Inc. Common Stock (ONCT) in Q2 2023, closing a stake of 356 shares — an estimated $5K sold.

Simplex Trading first reported a position in ONCT in Q4 2014 and held it in 17 quarters. The position peaked at $319K in Q1 2021. 52 funds tracked by Wall St. Rank hold ONCT as of Q2 2023.

  • Simplex Trading reported no remaining Oncternal Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Simplex Trading sold 356 Oncternal Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $5K.
  • Simplex Trading first reported a position in Oncternal Therapeutics, Inc. Common Stock in Q4 2014 and held it in 17 quarters.
  • Simplex Trading's Oncternal Therapeutics, Inc. Common Stock position peaked at $319K in Q1 2021.
  • 52 funds tracked by Wall St. Rank held Oncternal Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Simplex Trading's 13F filing for Q2 2023, filed 4 Aug 2023.